UC Riverside engineers are developing low-cost, robotic “clothing” to help children with cerebral palsy gain control over their arm movements. Cerebral palsy is the most common cause of serious physical disability in childhood, and the devices envisioned for this project are meant to offer long-term daily assistance for those living with it. However, traditional robots
0 Comments
A new approach developed by Harvard Medical School researchers uses yeast to rapidly evolve synthetic antibody fragments called nanobodies with the aim to find variants that are effective at binding to selected antigens, including SARS-CoV-2. The antibodies are intended for use in diagnostic tests and disease treatments. Read the full story: https://hms.harvard.edu/news/antibody-evolution
0 Comments
Researchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancreatic ductal adenocarcinoma (PDAC). The researcher’s findings are published in Nature Cancer. Pancreatic ductal adenocarcinoma is one of the most lethal cancers.” Dr. Zhenkun Lou, Paper’s Senior Author Dr. Lou says while Poly-ADP-ribose-polymerase
0 Comments
Randomized comparisons of percutaneous coronary intervention (PCI) and coronary bypass surgery (CABG) for left-main coronary disease, including those that have sparked very public debate, naturally enrolled patients suitable for either procedure. But that takes a toll on their relevance to clinical practice, where patients are not so narrowly defined. It also highlights the role of
0 Comments
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. We’re letting our stocks run on Fed day Companies with pricing power are winners here Quick mentions: CSCO, NVDA, QCOM, MRVL, CRM 1. We’re letting our stocks run on Fed
0 Comments
Critical Path Institute (C-Path) has announced it will serve as the convener of the Critical Path for Rare Neurodegenerative Diseases (CP-RND), a new public-private partnership (PPP) to benefit people across multiple rare neurodegenerative diseases, supported by a grant from the U.S. Food and Drug Administration (FDA). The Agency announced the PPP today in a press
0 Comments
The American Academy of Sleep Medicine (AASM) issued a health advisory Wednesday encouraging parents to seek medical advice before giving melatonin or any supplement to children. “While melatonin can be useful in treating certain sleep-wake disorders like jet lag, there is much less evidence it can help healthy children or adults fall asleep faster,” M.
0 Comments